the elasticity of innovation with respect to the expected price of drugs should be at least as great as the elasticity of … innovation with respect to expected market size (disease incidence). I examine the cross-sectional relationship between … pharmaceutical innovation and market size among a set of diseases (different types of cancer) exhibiting substantial exogenous …

the elasticity of innovation with respect to the expected price of drugs should be at least as great as the elasticity of … innovation with respect to expected market size (disease incidence). I examine the cross-sectional relationship between … pharmaceutical innovation and market size among a set of diseases (different types of cancer) exhibiting substantial exogenous …

I analyze the effects of four types of medical innovation and cancer incidence on US cancer mortality rates during the … pre‐dated factors that drove both innovation and mortality and that there would have been parallel trends in mortality in … the absence of innovation, the estimates indicate that there were three major sources of the 13.8% decline of the age …

contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health …

Assessing the benefits of medical innovation—its impact on health outcomes—is as important as assessing the costs … that investigates the benefits and costs of another broad category of medical innovation—inpatient therapeutic procedure … innovation—using data on over one million hospital discharges. …